S
KYTX icon

SignatureFD’s Kyverna Therapeutics KYTX Stock Holding History

SignatureFD’s Portfolio KYTX Stock Details KYTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.15K Buy
+466
New +$4.14K ﹤0.01% 2922
2024
Q4 		– Sell
-314
Closed -$1.53K – 3420
2024
Q3 		$1.53K Buy
+314
New +$2.42K ﹤0.01% 2899

Other funds holding KYTX

YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
SIC
Samalin Investment Counsel Chappaqua, New York $320M AUM 20.87% 1-Year Est. Return
CAI
Capital Advisors Inc Tulsa, Oklahoma $6.8B AUM 26.96% 1-Year Est. Return
GWM
GSB Wealth Management Guilford, Connecticut $498M AUM 27.51% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
TFM
TFC Financial Management Boston, Massachusetts $902M AUM 21.74% 1-Year Est. Return

SignatureFD's KYTX Position: Q2 2026 in Review

SignatureFD opened a new position in Kyverna Therapeutics (KYTX) in Q2 2026: 466 shares worth $4.15K. The stake represents ﹤0.01% of the portfolio and ranks #2922 among its holdings. This is a return to the name: SignatureFD previously reported a position in KYTX as recently as Q3 2024.

SignatureFD first reported a position in KYTX in Q3 2024 and has held it in 2 quarters since. 13 funds tracked by Wall St. Rank hold KYTX as of Q2 2026.

  • SignatureFD held 466 shares of Kyverna Therapeutics worth $4.15K as of Q2 2026.
  • Kyverna Therapeutics was a new SignatureFD position in Q2 2026.
  • Kyverna Therapeutics made up ﹤0.01% of SignatureFD's portfolio in Q2 2026, its #2922 holding.
  • SignatureFD first reported a position in Kyverna Therapeutics in Q3 2024 and has held it in 2 quarters since.
  • 13 funds tracked by Wall St. Rank held Kyverna Therapeutics as of Q2 2026.

Based on SignatureFD's 13F filing for Q2 2026, filed 24 Jul 2026.